BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24748476)

  • 21. BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure.
    Singh KK; Shukla PC; Quan A; Desjardins JF; Lovren F; Pan Y; Garg V; Gosal S; Garg A; Szmitko PE; Schneider MD; Parker TG; Stanford WL; Leong-Poi H; Teoh H; Al-Omran M; Verma S
    J Biol Chem; 2012 Feb; 287(9):6604-14. PubMed ID: 22157755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxorubicin attenuates CHIP-guarded HSF1 nuclear translocation and protein stability to trigger IGF-IIR-dependent cardiomyocyte death.
    Huang CY; Kuo WW; Lo JF; Ho TJ; Pai PY; Chiang SF; Chen PY; Tsai FJ; Tsai CH; Huang CY
    Cell Death Dis; 2016 Nov; 7(11):e2455. PubMed ID: 27809308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
    Zhang C; Feng Y; Qu S; Wei X; Zhu H; Luo Q; Liu M; Chen G; Xiao X
    Cardiovasc Res; 2011 Jun; 90(3):538-45. PubMed ID: 21278141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of heat shock protein 70 blocks the development of cardiac hypertrophy by modulating the phosphorylation of histone deacetylase 2.
    Yoon S; Kim M; Min HK; Lee YU; Kwon DH; Lee M; Lee S; Kook T; Joung H; Nam KI; Ahn Y; Kim YK; Kim J; Park WJ; McMullen JR; Eom GH; Kook H
    Cardiovasc Res; 2019 Nov; 115(13):1850-1860. PubMed ID: 30596969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice.
    Zhang Y; Kang YM; Tian C; Zeng Y; Jia LX; Ma X; Du J; Li HH
    PLoS One; 2011; 6(6):e21104. PubMed ID: 21738612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA.
    Bae S; Siu PM; Choudhury S; Ke Q; Choi JH; Koh YY; Kang PM
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1374-81. PubMed ID: 20833960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes.
    Kawaguchi T; Takemura G; Kanamori H; Takeyama T; Watanabe T; Morishita K; Ogino A; Tsujimoto A; Goto K; Maruyama R; Kawasaki M; Mikami A; Fujiwara T; Fujiwara H; Minatoguchi S
    Cardiovasc Res; 2012 Dec; 96(3):456-65. PubMed ID: 22952253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
    Schwarz B; Percy E; Gao XM; Dart AM; Richardt G; Du XJ
    Eur J Heart Fail; 2003 Mar; 5(2):131-6. PubMed ID: 12644002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
    Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice.
    Keller K; Maass M; Dizayee S; Leiss V; Annala S; Köth J; Seemann WK; Müller-Ehmsen J; Mohr K; Nürnberg B; Engelhardt S; Herzig S; Birnbaumer L; Matthes J
    Cardiovasc Res; 2015 Dec; 108(3):348-56. PubMed ID: 26464333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation.
    Bernardo BC; Sapra G; Patterson NL; Cemerlang N; Kiriazis H; Ueyama T; Febbraio MA; McMullen JR
    PLoS One; 2015; 10(12):e0145173. PubMed ID: 26660322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
    Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice.
    Villeneuve C; Guilbeau-Frugier C; Sicard P; Lairez O; Ordener C; Duparc T; De Paulis D; Couderc B; Spreux-Varoquaux O; Tortosa F; Garnier A; Knauf C; Valet P; Borchi E; Nediani C; Gharib A; Ovize M; Delisle MB; Parini A; Mialet-Perez J
    Antioxid Redox Signal; 2013 Jan; 18(1):5-18. PubMed ID: 22738191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p300 protects cardiac myocytes from apoptosis in vivo.
    Kawamura T; Hasegawa K; Morimoto T; Iwai-Kanai E; Miyamoto S; Kawase Y; Ono K; Wada H; Akao M; Kita T
    Biochem Biophys Res Commun; 2004 Mar; 315(3):733-8. PubMed ID: 14975762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling.
    Li X; Chan TO; Myers V; Chowdhury I; Zhang XQ; Song J; Zhang J; Andrel J; Funakoshi H; Robbins J; Koch WJ; Hyslop T; Cheung JY; Feldman AM
    Circulation; 2011 Aug; 124(5):572-81. PubMed ID: 21747049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHIP enhances angiogenesis and restores cardiac function after infarction in transgenic mice.
    Xu CW; Zhang TP; Wang HX; Yang H; Li HH
    Cell Physiol Biochem; 2013; 31(2-3):199-208. PubMed ID: 23485987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice.
    Zou Y; Li J; Ma H; Jiang H; Yuan J; Gong H; Liang Y; Guan A; Wu J; Li L; Zhou N; Niu Y; Sun A; Nakai A; Wang P; Takano H; Komuro I; Ge J
    J Mol Cell Cardiol; 2011 Nov; 51(5):821-9. PubMed ID: 21854784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation.
    Schirone L; Vecchio D; Valenti V; Forte M; Relucenti M; Angelini A; Zaglia T; Schiavon S; D'Ambrosio L; Sarto G; Stanzione R; Mangione E; Miglietta S; Di Bona A; Fedrigo M; Ghigo A; Versaci F; Petrozza V; Marchitti S; Rubattu S; Volpe M; Sadoshima J; Frati L; Frati G; Sciarretta S
    Cell Mol Life Sci; 2023 Aug; 80(9):245. PubMed ID: 37566283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.